InvestorsHub Logo
Followers 42
Posts 5826
Boards Moderated 0
Alias Born 12/16/2005

Re: volgoat post# 143663

Friday, 10/04/2013 6:13:14 PM

Friday, October 04, 2013 6:13:14 PM

Post# of 346701
When will BXQ-350 nanovesicles be available for treating cancer patients?

Clinical research in cancer patients is being planned, and the first-in-human phase I research studies are scheduled to begin in 2013. Product commercial availability will depend on successful clinical test results in cancer patients and regulatory approvals world-wide
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent CDMO News